Results 171 to 180 of about 491,703 (337)

Conservative hysteroscopic treatment of endometrial intraepithelial neoplasia and endometrial cancer in patients with high surgical risk with mechanical hysteroscopic tissue removal systems: A retrospective cohort study

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare surgical and oncologic outcomes between conventional resectoscopic surgery and mechanical hysteroscopic tissue removal (mHTR) systems in high‐risk patients not suitable for standard surgery undergoing conservative treatment for multifocal endometrial atypical hyperplasia/endometrial intraepithelial neoplasia (EAH/EIN) or ...
Alessandro Arena   +9 more
wiley   +1 more source

Intraoperative Ultrasound as a Decision-Making Tool in Modern Gynecologic Oncology. [PDF]

open access: yesJ Pers Med
Lakany M   +8 more
europepmc   +1 more source

Cancer of the vagina: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Primary vaginal cancer is a rare gynecologic malignancy, with most vaginal cancers representing metastases from other primary sites. Staging and treatment protocols are often extrapolated from those used in cervical cancer. In contemporary medicine, the roles of the pathologist and radiologist are increasingly vital in supporting diagnosis and
Tracey S. Adams   +2 more
wiley   +1 more source

Prognostic relevance of carbonic anhydrase-IX in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study [PDF]

open access: green, 2009
Shu‐Yuan Liao   +9 more
openalex   +1 more source

Revisiting intraperitoneal chemotherapy for advanced high‐grade serous ovarian cancer

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To compare overall survival (OS) in patients with high‐grade serous ovarian cancer (HGSOC) treated with intraperitoneal (IP) chemotherapy versus intravenous (IV) chemotherapy. Methods A retrospective study of Stage III HGSOC with optimal primary cytoreduction during 2007–2019, followed by adjuvant IP or IV chemotherapy.
Joshua S Cheruvathur   +7 more
wiley   +1 more source

Adnexal mass referral patterns in Gynecologic Oncology. [PDF]

open access: yesGynecol Oncol Rep
Bajpai R   +4 more
europepmc   +1 more source

Patient centered care for placenta accreta spectrum: Exploring implementation of recommendations based on reported patient and healthcare provider experiences

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Previously, we made recommendations for “family‐centered care” for patients with placenta accreta spectrum (PAS). This study explored patients' experience of their care and how often these recommendations are utilized. Furthermore, we explored whether these recommendations are valued by healthcare providers and identify barriers to ...
Helena C. Bartels   +7 more
wiley   +1 more source

Prophylactic and Therapeutic Usage of Drains in Gynecologic Oncology Procedures: A Comprehensive Review. [PDF]

open access: yesJ Pers Med
Margioula-Siarkou C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy